(Q46287030)

21 December 2017

title

BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components (English)

1 reference

21 December 2017

1 reference

11

Masahiko Sugita

1 reference

21 December 2017

Isamu Matsunaga

3

object named as

Isamu Matsunaga

1 reference

21 December 2017

author name string

Yoshiyuki Watanabe

1

1 reference

21 December 2017

Eiji Watari

2

1 reference

21 December 2017

Kenji Hiromatsu

4

1 reference

21 December 2017

Christopher C Dascher

5

1 reference

21 December 2017

Tetsuo Kawashima

6

1 reference

21 December 2017

Yoshihiko Norose

7

1 reference

21 December 2017

Kazuo Shimizu

8

1 reference

21 December 2017

Hidemi Takahashi

9

1 reference

21 December 2017

Ikuya Yano

10

1 reference

21 December 2017

language of work or name

English

0 references

publication date

11 May 2006

1 reference

21 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 December 2017

volume

24

1 reference

21 December 2017

issue

29-30

1 reference

21 December 2017

page(s)

5700-5707

1 reference

21 December 2017

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

BCG vaccination against tuberculosis: past disappointments and future hopes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Immunity to intracellular bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

T cell activation by lipopeptide antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

CD1-restricted T cell recognition of microbial lipoglycan antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Dendritic Cells Are Host Cells for Mycobacteria In Vivo That Trigger Innate and Acquired Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

An antimicrobial activity of cytolytic T cells mediated by granulysin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Differential effects of cytolytic T cell subsets on intracellular infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Cutting edge: major CD8 T cell response to live bacillus Calmette-Guérin is mediated by CD1 molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Characterization of guinea-pig group 1 CD1 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Molecular recognition of lipid antigens by T cell receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Immune reactions of CD4- and CD8-positive T cell subpopulations in spleen and lymph nodes of guinea pigs after vaccination with Bacillus Calmette Guerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Conservation of CD1 intracellular trafficking patterns between mammalian species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Separate pathways for antigen presentation by CD1 molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Advances in antibody-mediated immunity againstMycobacterium tuberculosis: implications for a novel vaccine strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Clinical evaluation of anti-tuberculous glycolipid immunoglobulin G antibody assay for rapid serodiagnosis of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Ammonium chloride, an inhibitor of phagosome-lysosome fusion in macrophages, concurrently induces phagosome-endosome fusion, and opens a novel pathway: studies of a pathogenic mycobacterium and a nonpathogenic yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

CD1c molecules broadly survey the endocytic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Mycobacteria target DC-SIGN to suppress dendritic cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.049

10.1016/J.VACCINE.2006.04.049

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017